Should Pharmaceutical Companies Have A Conflict Of Interest

The fact that patience fear and anxiety are being taken advantage of, makes you ponder and asked the following questions. Where is our human empathy? What is our social responsibility? Is money more important than human life? Should pharmaceutical companies raise the price of older prescription to the same cost of newer prescriptions? What happen when doctors stand up against the pharmaceutical companies and the media exposing excessive greed? Seeing patience going bankrupt while CEOs of drug companies and doctors are living large, is absolutely despicable. In this assignment, I will attempt to bring to light my opinion about any negotiation, possible conflicts of interest and what our social responsibility entails. Since the highly successful

Leonard Salt spoke about the financial toxicity of these drug price and how pharmaceutical companies are clearly taking advantage of patience. Pharmaceutical companies are completely aware that cancer diagnosis is one of the leading cause of bankruptcy in America, yet, they turned a blind eye to this reality. Why does this occur; especially, knowing the insurance company will pay? Yes, the insurance company will pay, but only a portion, leaving the patient to remunerate the remaining cost. Cancer is the second leading cause of death in America, such a shame. While government official or other regulatory leaders in other countries negotiate the cost of drugs, the old laissez-faire ‘let it be’ mentality remain strong in America; essentially, demonstrating the prevailing capitalism system. Since Medicaid endure the hefty price tag, they should have negotiating power over the final cost of the

Upon seeing the cost of Zaltrap and recognizing its effect, Dr. Saltz became infuriated. Why? Avastin has the same chemical, provide the same result and cost lower; however, Zaltrap has more toxicity and cost twice the amount of Avastin, as Saltz called their comparison, “like coke and pepsi.” (Bonin, 2014) Had it not been for the rejection of Dr. Saltz, Dr. Daniel Barrett, the media, Medicaid and others, the cost of Zaltrap would have spiraled through the doors of insurance companies and into the pockets of patience, sending even more bankrupt or decease. Doctors who willing accept kickbacks from pharmaceutical companies for forcing their drugs on patience, have committed a conflict of interest. Patience has a free open market; therefore, no doctor should force one drug over another, for the sake of a payout. Those who participate in such behavior, should face disciplinary actions, including but not limited to termination by the medical board, preventing them from working in the medical field and